Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): comment on the appraisal consultation from the British Thoracic Oncology Group

Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): comment on the appraisal consultation from the British Thoracic Oncology Group

Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): comment on the appraisal consultation from the British Thoracic Oncology Group
10 March 2011
(4.76 Kb 1 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 08 March 2011